ClinConnect ClinConnect Logo
Search / Trial NCT06358404

Developing a Peer Support Intervention for Depression in SCD

Launched by MASSACHUSETTS GENERAL HOSPITAL · Apr 5, 2024

Trial Information

Current as of July 25, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking to see if a new program can help older adults who are experiencing both depression and some memory issues, known as subjective cognitive decline. The program lasts for 8 weeks and involves peer coaches—people who have similar experiences—providing support and care to participants. The goal is to find out how well this approach works and if participants feel comfortable with it.

To be eligible for this study, you need to be at least 60 years old, have some memory concerns, and show signs of depression, but you should not be experiencing severe mental health issues like active suicidal thoughts or untreated serious mental illnesses. This trial is not yet recruiting participants, but if you fit these criteria, you may have the opportunity to join and receive help tailored to your needs. Throughout the trial, participants can expect to engage in supportive sessions with their peer coaches, providing them with tools and strategies to manage their emotions and improve their mental well-being.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Older adults aged 60+
  • Endorse subjective cognitive decline
  • Endorse depressive symptoms
  • not currently experiencing suicidal ideation nor active, untreated manic, psychotic, or substance use disorder
  • fluent in English and able to give informed consent
  • Exclusion Criteria:
  • Meets diagnostic criteria for mild cognitive impairment or Alzheimer's dementia
  • Meets diagnostic criteria for a current major depressive disorder
  • have a history of neurological and psychiatric comorbidities such as major depressive disorder in the past 12 months

About Massachusetts General Hospital

Massachusetts General Hospital (MGH) is a leading academic medical center located in Boston, Massachusetts, renowned for its commitment to advancing medical research and patient care. As a prominent teaching hospital affiliated with Harvard Medical School, MGH plays a pivotal role in clinical trials across a wide range of disciplines, including cardiology, oncology, neurology, and more. The institution is dedicated to fostering innovative research that translates into effective therapies and improved health outcomes. MGH's Clinical Trials Office provides comprehensive support to facilitate the design, implementation, and management of clinical studies, ensuring adherence to the highest ethical standards and regulatory compliance. With a focus on collaboration and patient-centered care, MGH strives to enhance medical knowledge and contribute to the future of healthcare.

Locations

Boston, Massachusetts, United States

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported